4.7 Article

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 64, Issue 3, Pages 599-606

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkp232

Keywords

HIV; ARV; HAART; self-reports; selection models; Heckman two-step

Funding

  1. Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)
  2. College des Universitaires de Maladies Infectieuses et Tropicales (CMIT ex APPIT)
  3. Sidaction Ensemble contre le Sida
  4. Abbott
  5. Boehringer-Ingelheim
  6. Bristol-Myers Squibb
  7. GlaxoSmithKline
  8. Roche

Ask authors/readers for more resources

Objectives: The aim of this study was to identify factors associated with non-adherence over a 10 year follow-up of the APROCO-COPILOTE cohort during the maintenance phase of highly active antiretroviral therapy (HAART). Methods: Overall, 1010 patients participated in this analysis, each having had at least 12 months of follow-up after HAART initiation and at least one self-reported adherence measure available during the follow-up period (month 12-month 120). Data collection was based on clinical records and self-administered questionnaires that gathered patients' psychosocial characteristics and experience with HIV disease and treatment. First, a generalized estimating equations (GEE) model was used to identify non-adherence predictors. Secondly, a Heckman two-stage approach was used in order to account for missing data bias and to measure the extent to which this could affect the results of the first model. Results: Non-adherent behaviour was reported by 747 patients (2070 visits). After correcting for the bias due to missing data, non-adherence was independently associated with side effects, having a three times or more daily dosing regimen, experience of being at clinical stage B/C and being diagnosed as HIV-positive for < 6 months. Non-adherence was more likely among patients who were younger, had children, were born in the European Union, had depressive symptoms, consumed alcohol daily and declared a lack of support from their main partner. Adjusting for missing outcome data changed the pattern of predictors. Conclusions: Reasons for non-adherence depended on both psychosocial conditions and treatment-related characteristics. To improve long-term patient outcomes for those at risk of adherence failure, tailor-made patient-specific psychosocial interventions and regimen-based strategies with improved tolerance need to be implemented.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort

P. Roux, M. Jauffret-Roustide, C. Donadille, L. Briand Madrid, C. Denis, I Celerier, C. Chauvin, N. Hamelin, G. Maradan, M. P. Carrieri, C. Protopopescu, L. Lalanne, M. Auriacombe

Summary: This study using data from the French COSINUS cohort found that drug consumption rooms (DCRs) have a positive impact on the health of people who inject drugs (PWID). DCR-exposed participants were less likely to report overdoses, abscesses, and emergency department visits. These findings support the expansion of DCR implementation to improve the injection environment and health of PWID.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2023)

Article Immunology

Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV Centre

Romain Palich, Rachid Agher, Dimoke J. Wetshikoy, Lise Cuzin, Sophie Seang, Cathia Soulie, Roland Tubiana, Marc-Antoine Valantin, Luminita Schneider, Valerie Pourcher, Anne-Genevieve Marcelin, Lambert Assoumou, Christine Katlama

Summary: This study aims to explore the differences in antiretroviral therapy (ART) prescriptions between naive and virally suppressed HIV patients born in France and Sub-Saharan Africa. The findings suggest that the differences in ART prescriptions between these two groups cannot solely be explained by different clinical and virologic situations.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2023)

Article Chemistry, Medicinal

Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potential

Peter J. Slavish, Maxime G. Cuypers, Mary Ashley Rimmer, Alireza Abdolvahabi, Trushar Jeevan, Gyanendra Kumar, Jamie A. Jarusiewicz, Sivaraja Vaithiyalingam, Jeremy C. Jones, John J. Bowling, Jeanine E. Price, Rebecca M. DuBois, Jaeki Min, Richard J. Webby, Zoran Rankovic, Stephen W. White

Summary: Influenza is a major cause of disease-related deaths globally. Strategies to inhibit influenza virus replication have resulted in the emergence of resistant strains. Baloxavir marboxil, a recently approved compound, is significantly less effective due to a mutation in the active site of the target enzyme. Raltegravir, an HIV inhibitor, shows moderate activity against the enzyme. In this study, researchers used structure-guided approaches to design molecules that effectively target the enzyme's active site and successfully developed potent inhibitors for both wild-type and baloxavir-resistant forms.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Infectious Diseases

Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort

Sophie Grabar, Valerie Potard, Lionel Piroth, Sophie Abgrall, Louis Bernard, Clotilde Allavena, Fabienne Caby, Pierre de Truchis, Claudine Duvivier, Patricia Enel, Christine Katlama, Marie-Aude Khuong, Odile Launay, Sophie Matheron, Giovanna Melica, Hugues Melliez, Jean-Luc Meynard, Juliette Pavie, Laurence Slama, Sylvie Bregigeon, Pierre Tattevin, Jacqueline Capeau, Dominique Costagliola

Summary: Many studies have found that starting an integrase strand-transfer inhibitor-based regimen for HIV-positive individuals who have not previously received antiretroviral therapy can lead to weight gain. This study examined the impact of early or advanced HIV disease progression and the specific drugs used in combination antiretroviral therapy (cART) on weight changes. The results showed that individuals with advanced disease progression experienced greater weight gain compared to those with early disease progression. The choice of antiretroviral drugs should take into account the risk of weight gain, particularly for patients with advanced disease or obesity.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Infectious Diseases

Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055

Antoine Bachelard, Valentina Isernia, Charlotte Charpentier, Aida Benalycherif, Marion Mora, Cecile Donadille, Claudine Duvivier, Karine Lacombe, Mayssam El Mouhebb, Bruno Spire, Roland Landman, Diane Descamps, Gilles Peytavin, Lambert Assoumou, Jade Ghosn, FAST sty grp

Summary: Initiating same-day ART for newly HIV-diagnosed individuals reduces transmission risk and improves treatment adherence. The BIC/FTC/TAF regimen has been shown to be safe, effective, and well accepted for same-day initiation.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Immunology

Human Immunodeficiency Virus (HIV) Seroconversion Among Men Who Have Sex With Men Who Use Event-driven or Daily Oral Pre-exposure Prophylaxis (CohMSM-PrEP): A Multi-country Demonstration Study From West Africa

Christian Laurent, Issifou Yaya, Benjamin Cuer, Luis Sagaon-Teyssier, Ephrem Mensah, Ter Tiero Elias Dah, Alou Coulibaly, Malan Jean-Baptiste Kouame, Gilles Peytavin, Laetitia Serrano, August Eubanks, Issa Traore, Fodie Diallo, Lucas Riegel, Daniela Rojas Castro, Claver A. Dagnra, Camille Anoma, Bea Vuylsteke, Bintou Dembele Keita, Bruno Spire

Summary: This study aimed to investigate HIV seroconversion, PrEP adherence, plasma drug concentrations, and HIV drug resistance among men who have sex with men (MSM) using event-driven or daily PrEP in West Africa. The results showed that participants who chose event-driven PrEP had higher HIV incidence and lower adherence. Improving adherence to event-driven PrEP is a major research and public health priority in this context.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Perception of PrEP-related stigma in PrEP users: Results from the ANRS-PREVENIR cohort

C. Protiere, L. Sagaon-Teyssier, C. Donadille, A. Sow, G. Gaubert, G. Girard, M. Mora, L. Assoumou, L. Beniguel, D. Michels, J. Ghosn, D. Costagliola, D. Rojas Castro, J. -M. Molina, B. Spire

Summary: Since the introduction of HIV pre-exposure prophylaxis (PrEP), stigma has been a significant barrier to its acceptance and adherence. This study aimed to determine the proportion of PrEP users who believe that taking PrEP can negatively affect their image and identify the factors associated with this perception.

HIV MEDICINE (2023)

Article Infectious Diseases

Low-level viral loads and virological failure in the integrase strand transfer era

Lise Cuzin, Philippe Flandre, Clotilde Allavena, Romain Palich, Claudine Duvivier, Agathe Becker, Helene Laroche, Pascal Pugliese, Andre Cabie, Dat'AIDS Study Grp

Summary: This study analyzed the occurrence of virological failure (VF) in patients starting ART with an integrase strand transfer inhibitor (INSTI)-based regimen in recent years and its relationship with previous episodes of low-level viral load (LLVL). The results showed that LLVL was associated with VF, and even in the absence of subsequent failure, LLV episodes have a cost. Therefore, any viral load value above 50 copies/mL should lead to enhanced adherence counseling.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Virology

Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children

Djeneba B. Fofana, Houdou Diarra, Ibrahima Guindo, Mahamadou K. Savadogo, Marceline d'Almeida, Fatoumata I. Diallo, Aliou Balde, Cathia Soulie, Amadou Kone, Anne-Genevieve Marcelin, Almoustapha I. Maiga, Sidonie Lambert-Niclot, Mamoudou Maiga, Sally McFall, Claudia A. Hawkins, Robert L. Murphy, Mariam Sylla, Christine Katlama, Jane L. Holl, Vincent Calvez, Laurence Morand-Joubert

Summary: Limited data exist on INI resistance in children living with HIV/AIDS in West Africa. A study was conducted on HIV-1-infected children in Benin and Mali, and it was found that no major INI resistance mutations were detected in INI-naive patients.

VIRUSES-BASEL (2023)

Article Medicine, General & Internal

CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada

Elisa Ruiz-Burga, Shema Tariq, Giota Touloumi, John Gill, Emily Jay Nicholls, Caroline Sabin, Cristina Mussini, Laurence Meyer, Alain Volny Anne, Christina Carlander, Sophie Grabar, Inma Jarrin, Marc Van der Valk, Linda Wittkop, Bruno Spire, Nikos Pantazis, Fiona M. Burns, Kholoud Porter

Summary: This study aims to understand the current drivers of the HIV epidemic in Europe, factors associated with access to, and uptake of prevention methods and ART initiation, and the experiences, needs, and outcomes of people with recently acquired HIV.

BMJ OPEN (2023)

Review Immunology

A systematic review of qualitative research on recently acquired HIV

Emily Jay Nicholls, Nicoletta Policek, Alain Volny-Anne, Bruno Spire, Fiona Burns, Elisa Ruiz-Burga, Shema Tariq, C. A. S. C. A. D. E. Collaboration CASCADE Collaboration

Summary: This systematic review and narrative synthesis of qualitative literature on recently acquired HIV provides insights into the contextual factors underlying HIV acquisition. The study finds that further research is needed to explore the emotional impact of indeterminate test results and negotiate risk reduction, as well as to investigate sexual risk, pre-exposure prophylaxis, and treatment as prevention in the context of recently acquired HIV.
Article Public, Environmental & Occupational Health

The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study

Thijs Reyniers, Marion Fiorentino, Stephane Alain Yoro Babo, Mamadou Ouedraogo, Ibrahima Kanta, Laurette Ekon Agbegnigan, Daniela Rojas, Camille Anoma, Ter Tiero Elias Dah, Ephrem Mensah, Bintou Dembele Keita, Bruno Spire, Bea Vuylsteke, Christian Laurent, CohMSM PrEP Study Grp

Summary: This study explored the perceived added value of bimonthly long-acting injectable pre-exposure prophylaxis (LAI-PrEP) as an HIV prevention tool among MSM in Burkina Faso, Cote d'Ivoire, Mali, and Togo. The results showed that LAI-PrEP was perceived to provide better protection against HIV and be more convenient compared to condoms and oral PrEP. However, concerns about needle fear, doubts about efficacy, potential side effects, and difficulties in ensuring timely injections were also identified. Increasing awareness about HIV and addressing discrimination based on sexual orientation remain crucial for HIV prevention.

AIDS PATIENT CARE AND STDS (2023)

Review Public, Environmental & Occupational Health

Assessing complex interventions: a systematic review of outcomes used in randomised controlled trials on STI partner notification in high-income countries

Victoire Sawras, Sylvie Deuffic-Burban, Marie Preau, Bruno Spire, Yazdan Yazdanpanah, Karen Champenois

Summary: This review explores the effectiveness of partner notification interventions for STIs and HIV, and identifies the need for more comprehensive outcomes and data to better understand the impact of these interventions.

BMC PUBLIC HEALTH (2023)

Article Immunology

A Randomized Controlled Trial to Study the Transmission of SARS-CoV-2 and Other Respiratory Viruses During Indoor Clubbing Events (ANRS0066s ITOC Study)

Liem Binh Luong Nguyen, Jeanne Goupil de Bouille, Lola Menant, Marion Noret, Audrey Dumas, Maud Salmona, Jerome Le Goff, Constance Delaugerre, Pascal Crepey, Jeremy Zeggagh, ITOC Study Grp

Summary: In the context of low circulation of the Delta variant, there was no evidence of SARS-CoV-2 transmission among fully vaccinated participants in an indoor clubbing event. However, there was an increased risk of other respiratory virus infection.

CLINICAL INFECTIOUS DISEASES (2023)

Letter Gastroenterology & Hepatology

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH)

Tangui Barre, David Zucman, Fabienne Marcellin, Clemence Ramier, Camelia Protopopescu, Raphaelle Tardieu, Karine Ory, Dominique Salmon-Ceron, Patrizia Carrieri

JOURNAL OF VIRAL HEPATITIS (2023)

No Data Available